Abstract: A method and a control device determine a position-related braking ability of a vehicle. A first vehicle determines at least one piece of position-related information of a route section, the at least one piece of position-related information of the route section being information relating to the braking ability on the route section. The first vehicle transmits the at least one piece of position-related information to a receiver, the receiver being at least one second vehicle, whereby the braking curves of at least one rail vehicle are adapted according to the situation, thus allowing safety on the route section and the utilization of the section to be improved.

Abstract: The invention relates to a functional footwear unit, in particular in the form of knit-of-parts, which has preferably a particularly modular protective function against chemical and/or biological toxic and/or harmful substances, especially warfare agents. The invention also relates to the uses thereof.

Abstract: The invention relates to a functional footwear unit, in particular in the form of knit-of-parts, which has preferably a particularly modular protective function against chemical and/or biological toxic and/or harmful substances, especially warfare agents. The invention also relates to the uses thereof.

Abstract: The technology provided herein generally relates to novel specific photoimmuno-theranostics for the use in detection and elimination of skin cancer cells. The technology also relates to novel methods which generate homogeneous and specific photoimmuno-theranostics reagents in a simple, controlled and efficient way. This method combines molecular optical imaging, photodynamic therapy and immunotherapy using SNAP-tag technology.

Abstract: The technology provided herein relates to methods of multi-species insect pest control by incorporating an inhibitor against the structural sheath protein (SHP) into the body of an agricultural target pest, and to pest control agents to be used in the method and to transgenic crop, greenhouse and ornamental plants.

Abstract: The present invention relates to a sheet filter material, in particular having an aerosol filter function and/or a particle filter function, preferably having a protective function against chemical, biological and/or chemical harmful and toxic substances, and to a method for the production thereof. The sheet filter material is particularly suitable for producing protective equipment, protective objects, sports and leisure clothing and filters and filter materials of all types.

Abstract: A supplemental device for attachment to an injection device, the supplemental device comprising: an imaging arrangement configured to capture an image of one or more numbers present on a moveable component of the injection device; and a processor arrangement configured to run a first algorithm to: receive data representing an image; determine the position of at least one number in the image by determining the boundaries of each visible number; select one of the visible numbers to be identified; perform a pattern matching process to identify the value of the selected number; and determine a dose dialled into the injection device using the determined position of the selected one of the at least one visible number in the image.

Abstract: The invention relates to a functional footwear unit, in particular in the form of knit-of-parts, which has preferably a particularly modular protective function against chemical and/or biological toxic and/or harmful substances, especially warfare agents. The invention also relates to the uses thereof.

Abstract: The present invention is directed to nucleic acid sequences coding for a protein which, (1) under a respective promoter, is able to suppress or repress or delay flowering of a plant, and (2) includes the motive “NAPDIIDS” (SEQ ID NO: 10) or, in preferred cases, “VNAPDIIDS” SEQ ID NO: 67), with the exception of the nucleic acid of the gene StSP5G or a part thereof. Preferably, the nucleic acid sequence belongs phylogenetically to the FT-clade of the PEBP gene family, wherein the motive “(V)NAPDIIDS” (SEQ ID NO: 68) is in place of the “(V)YAPGW” motive (SEQ ID NO: 69) of the flowering promoting proteins AtFT and BvFT2. The invention is further directed to peptides or proteins, obtainable by expression of the nucleic acid of any of the preceding claims, vectors, comprising a nucleic acid sequence as defined above, and to plants, parts of plants, or seed of plants, the plants comprising such a nucleic acid sequence.

Abstract: This disclosure concerns the systems, methods, and kits for the in vitro synthesis of biological macromolecules in a reaction utilizing cell lysates containing plastids, mitochondria and/or chloroplasts, wherein creatine phosphate and creatine kinase are not added to the reaction to provide artificial energy regeneration.

Abstract: A piston for an internal combustion engine may include a piston skirt extending in a piston longitudinal direction and defined in the piston longitudinal direction by a piston head. The piston skirt may include a boxed interior space defined by two box walls and two substantially opposing skirt walls. A boss having a through-opening may be arranged on each of the two box walls, the two through-openings being oriented so that they align with one another. The two box walls may each include a boss portion oriented perpendicularly to the boss, and at least one intermediate portion extending between the respective boss portion and one of the skirt walls. The intermediate portion may merge via a bend into the associated boss portion. A radial extent of the boss portion may be greater than a diameter of the through-opening and at least 50% of a diameter of the piston.

Abstract: Complexes suitable for targeting and killing a human target cell comprising a first polypeptide with a binding structure for binding the complex to the cellular surface receptor CD89 (e.g. with an anti CD89 antibody) presented on the cell surface of the human target cell and a second polypeptide comprising a toxic effector domain, preferably Pseudomonas exotoxin A); to nucleic acid molecules encoding said complexes, vectors, host cells containing the nucleic acids and methods for preparation and producing such complexes; compositions and methods for using said complexes for the treatment of diseases, in particular of cancer diseases like leukemia.

Abstract: This disclosure concerns the systems, methods, and kits for the in vitro synthesis of biological macromolecules in a reaction utilizing cell lysates containing plastids, mitochondria and/or chloroplasts, wherein creatine phosphate and creatine kinase are not added to the reaction to provide artificial energy regeneration.

Abstract: The technology provided herein relates to novel human antibodies against Plasmodium parasites, in particular against the malaria parasite Plasmodium falciparum. The present disclosure pertains to antibodies against apical membrane antigen 1 (AMA-1). These antibodies have high affinity e.g. to Plasmodium falciparum schizonts and merozoites, inhibit the reinvasion of merozoites into erythrocytes and thereby neutralize parasitic multiplication.

Abstract: The technology provided herein generally relates relates to genetically modified higher plants, for example C3 and C4 plants, and subsequent generations thereof, comprising stable and/or transient expression of at least one gene-product (e.g. mRNA or protein) of the “Chlamydomonas reinhardtii CO2 concentrating mechanism” (CCM), wherein the expression takes place in the intermembrane space and/or one or more subcellular compartments of the chloroplasts of the higher plant, and wherein this expression increases one or more of the characteristics selected from the group of photosynthetic rate, photosynthetic carbon fixation, chlorophyll level and/or biomass of the genetically modified higher plant (T0) and/or of the T1 and/or T2 generation or any subsequent plant generation of said genetically modified higher plant.

Abstract: This disclosure concerns nucleic acid molecules and methods of use thereof for control of insect pests through RNA interference-mediated inhibition of target coding and transcribed non-coding sequences in insect pests, including coleopteran and/or hemipteran pests. The disclosure also concerns methods for making transgenic plants that express nucleic acid molecules useful for the control of insect pests, and the plant cells and plants obtained thereby.

Abstract: The invention provides a method for the generation of a monoclonal plant cell line from a heterologous population of plant cells, comprising the following steps: (a) provision of a heterologous population of plant cells; (b) preparation of protoplasts from said heterologous population of plant cells; (c) separation of single protoplasts by subjecting the preparation of protoplasts to flow cytometric sorting; (d) regeneration of a separated single transformed protoplast until the formation of a microcolony by co-cultivation in the presence of feeder cell material; (e) removal of the microcolony from the feeder cell material and cultivation of the microcolony until the formation of a monoclonal plant cell line.

Abstract: The invention relates to a microlens arrangement (12) and an illumination device (10) for uniformly illuminating of an area (F), with a light source (11) and a microlens arrangement (12). In order to illuminate the area (F) to be illuminated as homogeneously as possible, the at least one microlens (1) of the microlens arrangement (12) has an entrance face (2) which is shaped such that monochromatic light incident on the microlens (1) and propagating parallel to the optical axis (O) is refracted by the entrance face (2) such that back focal lengths (S1, S2, S3) of the light with the optical axis (O) increase with the height of incidence (E1, E2, E3).

Abstract: The invention relates to artificial forisome bodies including a fusion protein of at least one SEO-F protein or an at least 50-amino acid portion thereof, and at least one additional protein or peptide, with the exception of GFP and the Venus protein, wherein in an embodiment the forisome body further includes an unfused SEO-F protein or a form of the protein having C-terminal deletions of up to 45 amino acids and/or N-terminal deletions of up to 13 amino acids, wherein the unfused SEO-F protein is selected from proteins having the property of being capable of forming homomeric forisome bodies in the absence of additional SEO-F proteins.

Abstract: Artificial forisome bodies include a fusion protein of at least one SEO-F protein or an at least 50-amino acid portion of an SEO-F protein, and at least one additional protein or peptide, with the exception of GFP and the Venus protein. The additional protein or peptide has a mass of at most 30 kDa, or the forisome body further includes an unfused SEO-F protein or a form of the protein having C-terminal deletions of up to 45 amino acids and/or N-terminal deletions of up to 13 amino acids, in which the unfused SEO-F protein is a protein capable of forming homomeric forisome bodies in the absence of additional SEO-F proteins.